Navigation Links
Elsevier Aligns Solutions to Empower Meaningful Care
Date:2/28/2013

PHILADELPHIA, February 28, 2013 /PRNewswire/ --

Integrated clinical solutions from Elsevier, including new order sets, work to help healthcare providers achieve clinical, operational and financial excellence

Elsevier, a world-leading provider of scientific, technical and medical information products and services, has aligned its clinical decision support (CDS) and clinical reference solutions to help healthcare providers and payers achieve clinical, operational and financial excellence.

The latest example of this alignment is InOrder by Elsevier, an intuitive, cloud-based order set solution that enables clinicians to author, review and publish orders in a collaborative environment that quickly translates evidence-based knowledge into better patient care. By combining Elsevier's deep experience in providing evidence-based content and the capability to make updates rapidly as regulations and medications change, InOrder can help hospitals and clinicians increase patient safety and prevent medical errors.

"From analytics and reporting to evidence-based clinical information delivery, clinical practice transformation and patient education, Elsevier empowers meaningful care by providing a patient-centered approach to helping organizations achieve clinical, operational and financial excellence," said Jay Katzen , President of Elsevier's clinical solutions business. "As the healthcare industry continues to evolve, we are working hard to make it easier for providers and payers to achieve their best performance."

Elsevier will demonstrate its integrated solutions at its booth (#6129) at the Healthcare Information Management and Systems Society (HIMSS13) annual meeting in New Orleans, March 4-6. Using a
'/>"/>

SOURCE Elsevier
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Elsevier Names Dr. Jim Nolin Editor-in-Chief of Order Set Solution
2. Elsevier Announces the Launch of a New Journal: Methods in Oceanography
3. Elsevier Launches Evidence-Based, Collaborative Order Sets Solution
4. The Elsevier Foundation, TWAS, and OWSD Honor Early Career Women Scientists in Developing Countries at the Annual AAAS Meeting
5. Elsevier Announces the Launch of a New Journal: Journal of Forensic Radiology and Imaging
6. Elsevier and Kanazawa University in Japan Collaborate to Map Universitys Research Performance
7. Elsevier Welcomes New Editor-in-Chief for European Urology
8. Dr. Peter C. Neligan, Author of 3rd Edition of Elseviers Plastic Surgery Text, Available for Comment on the Contributions of Dr. Joseph Murray
9. Elsevier and the Dutch Fulbright Center Start Collaboration to Support Early Career Researchers in the Netherlands
10. Elsevier Offers Entire Collection of Journals and Books to Innovators in Developing Countries Through the Access to Research for Development and Innovation (ARDI) Program
11. Elsevier Acquires ExitCare, Provider of Patient Education Solutions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/25/2014)... California (PRWEB) October 23, 2014 ... a specialty pharmaceutical company devoted to bringing new ... partnerships in 2015. , ViaDerma has developed an ... allows for rapid mass transfer of pharmaceutical active ... body to provide immediate localized therapy. The transdermal ...
(Date:10/25/2014)... 24, 2014 The Workgroup ... leading nonprofit authority on the use of health ... announces its appointment of four new co-chairs to ... leaders include:, ,     Peter Dumont, Senior ... Pupo, Specialist Leader, Deloitte Consulting LLP , ...
(Date:10/25/2014)... A new way to produce engineered skin not ... grafting technologies, it also speeds up the healing process, ... the October issue of STEM CELLS Translational Medicine, could ... result from severe burns and chronic wounds. , A ... These wounds heal by contraction, with epithelization (the process ...
(Date:10/25/2014)... ROCKVILLE, Md. , Oct. 24, 2014  RegeneRx Biopharmaceuticals, ... on data presented at the Fourth International Symposium on ... , Italy.  "When thymosin beta ... was injected into the peritoneal cavity in a rodent ... vessels and throughout the brain parenchyma (the functional tissue ...
Breaking Biology Technology:ViaDerma, Inc. Announces Plans to Pursue Out-Licensing Partnerships in 2015 2ViaDerma, Inc. Announces Plans to Pursue Out-Licensing Partnerships in 2015 3WEDI Appoints Four New Security and Privacy Workgroup Co-chairs 2New engineering method shows promise for faster healing, more cosmetically appealing skin grafts 2New engineering method shows promise for faster healing, more cosmetically appealing skin grafts 3Researchers Report Thymosin Beta 4 Crosses Blood-Brain Barrier In Animal Stroke Model 2
... 13 , - Regulated Information, ThromboGenics ... innovative treatments for vascular disease, eye disease and,cancer, ... three month period ended,31 March 2008., Prof. ... on,today,s announcement, said: "ThromboGenics, clinical development programs,are continuing ...
... Nile Therapeutics, Inc.,(Nasdaq: NLTX ), today announced that ... the Rodman & Renshaw 5th Annual Global Healthcare,Conference at ... Meridian Beach,Plaza Hotel in Monte Carlo, Monaco. Mr. Strumph ... of Nile,s current clinical development,programs., The presentation will ...
... Foam Technology with Improved Usability & ... ... Despite the high incidence,of women,s health conditions that require intra-vaginal drug ... survey,found that an alarming majority of women find their current treatment,options ...
Cached Biology Technology:ThromboGenics N.V. - Business Update 2ThromboGenics N.V. - Business Update 3ThromboGenics N.V. - Business Update 4ThromboGenics N.V. - Business Update 5ThromboGenics N.V. - Business Update 6ThromboGenics N.V. - Business Update 7Nile Therapeutics to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference 272% of Women Are Dissatisfied With Their Current Treatment of Vaginal Infection, Survey Finds 2
(Date:10/22/2014)... 2014 The Nano-Bio Manufacturing Consortium (NBMC), an ... Laboratory (AFRL), has chosen a project proposed by the ... of Arizona College of Medicine – Tucson ... goal is to assess different sweat collection methods and ... sweat under a variety of human-body conditions, the results ...
(Date:10/18/2014)... Among a group of 2,000 patients referred for ... a potential molecular diagnosis for 25 percent, including ... and new mutations contributing to disease, according to ... study is being released to coincide with the ... Whole-exome sequencing analyzes the exons or coding regions ...
(Date:10/17/2014)... To date, antidotes ... doctors are often limited to supportive therapy such as induced ... of drugs involved. So what can be done if a ... professor Jean-Christophe Leroux from the Institute of Pharmaceutical Sciences at ... "The task was to develop an agent that could eliminate ...
Breaking Biology News(10 mins):Nano-Bio Manufacturing Consortium Selects Project Proposed by Arizona Center for Integrative Medicine to Optimize Human Performance Monitoring Techniques 2Nano-Bio Manufacturing Consortium Selects Project Proposed by Arizona Center for Integrative Medicine to Optimize Human Performance Monitoring Techniques 3Whole-exome sequencing shows potential as diagnostic tool 2Emergency aid for overdoses 2Emergency aid for overdoses 3
... Standards and Technology (NIST) and the German national ... sensor to successfully track a human heartbeat, confirming ... in Applied Physics Letters, * the study ... resembling a clinical setting with the NIST mini-sensors, ...
... Earth,s radiation balance by interacting with solar radiation ... organic compounds are key players in new particle ... role as the newly formed particles cool our ... aerosol (SOA) particles formed from volatile compounds emitted ...
... CAOCT. 13, 2010 -- Alzheimer,s disease (AD) is an ... in its cause and progression. For example, the lipid-transport ... factor for AD, and apoE4 carriers account for 65󈞼% ... to the disease is unclear. Scientists at ...
Cached Biology News:NIST mini-sensor traces faint magnetic signature of human heartbeat 2New research results change the understanding of atmospheric aerosol properties and climate effects 2Gladstone scientists uncover mechanism for the major genetic risk factor of Alzheimer's disease 2
Rabbit polyclonal to GPCR G2A ( Abpromise for all tested applications). entrezGeneID: 29933 SwissProtID: Q9UNW8...
... has been developed for use with ... of nonspecific background staining due to ... blocking peroxidase with hydrogen peroxide. ... combination with additional novel components to ...
Rabbit polyclonal to Wilms Tumor Protein ( Abpromise for all tested applications). entrezGeneID: 7490 SwissProtID: P19544...
Ku80 Antibody Shipping Temperature: HOT Storage Temperature: -20C...
Biology Products: